ThePricer Media
  • Latest: When Is an Electric Car Actually Cheaper?
  • Cost Guides
  • News & Investigations
  • Daily Price Puzzle (60s)
  • Methodology
  • Press & Mentions
  • Contact
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Fitness & Weight Loss, Health & Beauty

How Much Does Wegovy Cost?

Updated on September 22, 2026 | Researched and reviewed by Alec Pow, Founder & Pricing Investigator
Prices, claims, and calculations checked against 12 cited sources. See our research methodology and corrections policy.

Wegovy can currently cost anywhere from $25 to $1,349.02+ per month in the United States, but that enormous range is mostly explained by how you pay. Eligible commercially insured patients may pay as little as $25 per month, qualifying Medicare patients can pay $50 per month through the Medicare GLP-1 Bridge, and current manufacturer self-pay programs range from $149 to $399 per month depending on whether you use the Wegovy pill, standard pen, or Wegovy HD.

The official list price remains $1,349.02 per package before insurance, manufacturer discounts, rebates, or other savings. That makes the payment route more important than the sticker price when estimating what Wegovy will actually cost you.

Article Highlights

Jump to sections
  • How Much Does Wegovy Cost?
  • A Pill or Pen
  • Wegovy Without Insurance
  • What Does a Year of Wegovy Cost?
  • Commercial Insurance
  • Wegovy With Medicare
  • What About Medicaid?
★ Prefer ThePricer on Google
  • Official list price: $1,349.02 per package for the Wegovy pill or pen before discounts and insurance.
  • Wegovy pill self-pay: $149 per month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg or 25 mg under the current NovoCare program.
  • Standard Wegovy pen: eligible new self-pay patients currently pay $199 for each of the first two 0.25 mg and 0.5 mg fills, then $349 per month.
  • Wegovy HD: current self-pay pricing starts at $399 per month.
  • Commercial insurance savings: eligible patients may pay as little as $25, subject to a maximum manufacturer savings benefit of $100 per month.
  • Medicare GLP-1 Bridge: qualifying beneficiaries pay $50 per monthly supply through December 31, 2027.
How much does Wegovy cost

How Much Does Wegovy Cost?

The most useful way to answer the price question in 2026 is to separate list price, manufacturer self-pay pricing, commercial insurance, and Medicare.

How You Pay Current Cost Important Detail
Official list price $1,349.02/package Before insurance, rebates, or discounts
Wegovy pill self-pay $149-$299/month Price depends on tablet strength
New standard-pen self-pay patient $199/month initially First two 0.25 mg and 0.5 mg fills through the current 2026 offer
Standard Wegovy pen after intro offer $349/month Current self-pay price for standard injection strengths
Wegovy HD 7.2 mg $399/month Current manufacturer self-pay price
Eligible commercial insurance As little as $25/month Maximum savings benefit is $100 per month
Eligible Medicare GLP-1 Bridge $50/month Eligibility and prior authorization requirements apply

Novo Nordisk’s current official pricing information lists the Wegovy pill and pen at a list price of $1,349.02 per package.

That list price is important for understanding the drug’s underlying price, but it is no longer a good estimate of what every cash-paying patient will spend.

A Pill or Pen

One of the biggest changes since older Wegovy price guides were published is that Wegovy is no longer an injection-only medication.

The FDA approved Wegovy tablets for adults in December 2025. The pill is taken once daily, while the original Wegovy injection is administered once weekly.

Current tablet strengths are:

  • 1.5 mg
  • 4 mg
  • 9 mg
  • 25 mg

In March 2026, the FDA also approved Wegovy HD 7.2 mg, a higher-dose weekly injection for long-term weight reduction in certain adults.

These new formulations matter financially because the manufacturer’s self-pay prices are now different depending on which version and strength is prescribed.

Wegovy Without Insurance

For someone paying entirely out of pocket, the current manufacturer programs are far more relevant than the $1,349.02 list price.

According to the current self-pay offer, the Wegovy pill costs:

  • 1.5 mg: $149 per month
  • 4 mg: $199 per month
  • 9 mg: $299 per month
  • 25 mg: $299 per month

For the standard weekly pen, qualifying patients new to the Wegovy Savings Offer or NovoCare Pharmacy currently pay $199 for each of the first two monthly fills at the 0.25 mg and 0.5 mg strengths.

After that introductory period, current self-pay pricing is $349 per month for the 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg standard pen.

Wegovy HD 7.2 mg currently costs $399 per month through the same self-pay route.

The $199 introductory pen offer is currently scheduled through December 31, 2026, and Novo Nordisk states that it may modify or cancel these programs.

Related guides

  • How Much Does Hers Weight Loss Cost?
  • How Much Does Retatrutide Cost?

What Does a Year of Wegovy Cost?

The manufacturer’s current direct-pay program changes the yearly calculation dramatically.

A new standard-pen patient who receives two eligible introductory fills at $199 and then pays $349 for the following ten months would spend:

($199 × 2) + ($349 × 10) = $3,888 for the first 12 months.

Someone paying the current $349 self-pay price for all 12 months would spend:

$349 × 12 = $4,188 per year.

Compare that with paying full list price every month:

$1,349.02 × 12 = $16,188.24 per year.

That means the first example is roughly $12,300 less than 12 months at list price, assuming the current manufacturer program remains available and the patient qualifies.

These figures cover the medication itself. Medical appointments, laboratory tests, insurance premiums, or other care may be separate.

Commercial Insurance

Insurance coverage varies substantially by employer and health plan.

Novo Nordisk currently states that eligible people with commercial, non-government insurance may pay as little as $25 per month for covered Wegovy prescriptions.

There is an important limitation: the current savings benefit is capped at $100 per month.

For example, if your insurance already leaves you with a $90 copay, the card may be capable of reducing that amount to $25. But if your plan leaves you with a $300 obligation, a $100 maximum savings benefit does not magically turn the bill into $25.

This is why “as little as $25” should not be interpreted as the universal insured price.

Before filling the prescription, ask your insurer:

  • Whether Wegovy is on the formulary
  • Which Wegovy formulations are covered
  • Whether prior authorization is required
  • Your deductible status
  • Your copay or coinsurance
  • Whether step therapy applies
  • Whether the prescription must use a preferred pharmacy

Wegovy With Medicare

Medicare changed substantially in 2026.

Beginning July 1, 2026, CMS launched the Medicare GLP-1 Bridge. Eligible Medicare Part D beneficiaries can receive participating GLP-1 drugs for weight management with a $50 monthly copay.

The bridge currently runs through December 31, 2027.

That makes a full year at the bridge copay:

$50 × 12 = $600 per year.

Eligibility is not automatic. Current clinical eligibility rules require prior authorization and use specific BMI and medical-risk criteria.

Examples include:

  • BMI of at least 35, or
  • BMI of at least 30 with certain qualifying conditions, or
  • BMI of at least 27 with certain specified cardiovascular or metabolic risk factors.

The bridge is specifically designed for eligible weight-management use. Wegovy prescribed for a use already coverable under the standard Part D benefit, such as reducing major cardiovascular events in a patient who meets that approved indication, follows the ordinary Part D coverage pathway instead.

The $50 Bridge copay does not count toward the beneficiary’s normal Part D true out-of-pocket spending, and manufacturer coupons cannot be stacked on top of it.

What About Medicaid?

Medicaid coverage remains much less uniform.

As of January 2026, only 13 state Medicaid fee-for-service programs covered GLP-1 medications for obesity treatment, according to KFF.

States can also impose prior authorization and other utilization controls, and policies have been changing as states respond to the cost of GLP-1 treatment.

Someone covered by Medicaid should therefore check their current state program rather than relying on a national Wegovy copay estimate.

List Price Still Matters

The list price is not meaningless simply because discounted programs exist.

It can matter when:

  • Your insurance does not cover Wegovy
  • You are not eligible for a manufacturer program
  • A discount program changes or ends
  • Your deductible or coinsurance is tied to negotiated drug pricing
  • You purchase outside a qualifying manufacturer channel

List price is also different from the pharmacy’s retail cash price. Pharmacies, insurers, pharmacy benefit managers, and manufacturer programs can all produce different numbers from the same underlying product.

The safest comparison is therefore the final price you will actually pay for a 28-day or 30-day supply, not merely the pharmacy’s headline retail figure.

Compounded Semaglutide

Older pricing guides frequently described compounded semaglutide as a routine $300-$700 substitute for Wegovy. That framing is now misleading.

The FDA determined in February 2025 that the national shortage of semaglutide injection products had been resolved. The temporary enforcement periods that allowed wider production of essentially copied compounded semaglutide during the shortage subsequently ended.

Current federal compounding rules restrict routine production of essentially identical copies of commercially available approved products.

FDA also warns that unapproved compounded GLP-1 products do not undergo the same premarket review for safety, effectiveness, and quality as FDA-approved drugs. The agency says compounded drugs should generally be used when a patient’s medical needs cannot be met by an approved medication.

As of May 31, 2026, FDA reported receiving 990 adverse-event reports associated with compounded semaglutide, although an adverse-event report does not by itself establish that the compounded medicine caused the event.

For cost comparison purposes, compounded semaglutide should therefore not be presented simply as the “cheap generic Wegovy.” There is currently no generic Wegovy.

Wegovy vs Other GLP-1 Medications

Wegovy contains semaglutide, the same active ingredient used in Ozempic, but the products have different approved indications, dosage forms, and dosing schedules.

ThePricer has a separate breakdown of Ozempic costs for readers comparing semaglutide products.

Zepbound contains tirzepatide rather than semaglutide and has its own FDA-approved indications and pricing structure. See our guide to Zepbound costs for the current numbers.

For a broader comparison of GLP-1 and related treatments, see our breakdown of weight loss injection costs.

Price alone should not determine which prescription drug is appropriate. These medications differ in approved uses, dosing, contraindications, side effects, and individual clinical response.

Hidden Costs

The monthly medication price is not always the complete cost of treatment.

Medical appointments: A prescription requires evaluation and ongoing medical oversight. Telehealth companies may bundle this into a membership, while a physician’s office may bill visits separately.

Laboratory work: Some patients may require testing or monitoring based on their medical history and other medications.

Membership fees: A telehealth company’s advertised drug price may exclude its recurring platform or clinical-care fee.

Prior authorization: Completing prior authorization does not usually create a separate drug charge, but coverage delays can affect how and where a patient fills the prescription.

Changing insurance: A new employer or annual formulary change can sharply alter out-of-pocket cost even though the Wegovy prescription itself has not changed.

Always compare the medication price plus required program or clinical fees when assessing an online service.

Wegovy package

Who Is Wegovy Approved For?

Wegovy’s FDA-approved uses are broader than they were when many older cost articles were written.

The current prescribing information includes Wegovy injection for long-term weight reduction in adults with obesity, adults with overweight and at least one qualifying weight-related condition, and certain pediatric patients aged 12 and older with obesity.

Wegovy also has an approved indication to reduce the risk of cardiovascular death, nonfatal heart attack, or nonfatal stroke in adults with established cardiovascular disease and either obesity or overweight.

In August 2025, the FDA additionally approved Wegovy injection for certain adults with noncirrhotic MASH and moderate-to-advanced fibrosis under accelerated approval.

The Wegovy tablet is approved for adult weight reduction and cardiovascular-risk reduction indications but has not been established for pediatric weight reduction. Wegovy HD 7.2 mg was specifically approved for weight reduction and long-term weight maintenance in qualifying adults.

Wegovy is prescription medication with important contraindications, warnings, and adverse effects. Cost information should be used for budgeting, not to determine whether someone should start, stop, or change treatment.

What We Verified

Current prices: Manufacturer list price, tablet self-pay prices, standard-pen self-pay pricing, Wegovy HD pricing, and the current commercial savings offer were checked against Novo Nordisk’s September 2026 information.

New formulations: FDA records confirm the Wegovy tablet approval in December 2025 and the Wegovy HD 7.2 mg injection approval in March 2026.

Medicare: CMS currently sets the Medicare GLP-1 Bridge copay at $50 per monthly supply for eligible beneficiaries and states that the demonstration runs from July 1, 2026 through December 31, 2027.

Compounding: FDA records confirm that the semaglutide injection shortage was resolved in 2025 and that compounded semaglutide is not an FDA-approved generic version of Wegovy.

Calculations: Two introductory pen fills at $199 plus ten fills at $349 equal $3,888 for a 12-month example. Twelve months at the $1,349.02 list price equal $16,188.24.

Answers to Common Questions

How much is Wegovy without insurance in 2026?

Under the current manufacturer self-pay program, Wegovy can cost $149 to $399 per month depending on the formulation, dose, and whether a new patient qualifies for an introductory offer. The official list price remains $1,349.02 per package.

Is Wegovy still $499 per month?

The older $499 cash-pay program is no longer the best current price reference. Novo Nordisk’s September 2026 pricing lists standard Wegovy pens at $349 per month after the introductory period, Wegovy HD at $399, and Wegovy tablets at $149 to $299 depending on dose.

How do you get Wegovy for $25?

Eligible patients with commercial insurance can use the current manufacturer savings offer and may pay as little as $25 per month. The offer has a maximum savings benefit of $100 per month, so not every insured patient will end up at exactly $25.

How much is Wegovy with Medicare?

Eligible Medicare Part D beneficiaries using Wegovy for qualifying weight-management treatment through the Medicare GLP-1 Bridge currently pay $50 per month. Separate Medicare Part D rules apply when Wegovy is prescribed for an indication already covered through the standard Part D benefit.

How much does Wegovy cost per year?

At the current $349 standard-pen self-pay price, 12 months equal about $4,188. A qualifying new patient using two $199 introductory fills followed by ten $349 fills would spend about $3,888 over the first year under the present offer.

Does Wegovy now come as a pill?

Yes. The FDA approved Wegovy tablets in December 2025, and the once-daily pill became available in the United States in 2026.

Is there a generic Wegovy?

No FDA-approved generic Wegovy is currently available. Compounded semaglutide should not be described as generic Wegovy because compounded products are not FDA-approved equivalents.

Does Wegovy cost more at higher doses?

It depends on the formulation and payment program. The standard Wegovy injection currently has the same $349 self-pay price across its standard strengths after the introductory offer, while Wegovy tablets have different self-pay prices by dose and Wegovy HD is currently $399 per month.

Disclosure: Educational content, not medical advice. Pricing varies by provider, location, and insurance. Confirm eligibility, coverage, and out-of-pocket costs with a licensed clinician and your insurer. See our methodology and corrections policy.

by Alec Pow

We price things. We don't sell them.

  • No affiliate links
  • No paid placements
  • Independent since 2014

Cited in U.S. Army and congressional reports, peer-reviewed journals and national news.

How we research·Who cites us →
© 2026 - ThePricer Media, LLC, 4 Grove Street, New York, NY, 10014, Phone: (212) 431-2441
We don’t use affiliate links or paid placements. All sources are cited only for verification.
  • Link to X
  • Link to LinkedIn
  • Link to Facebook
  • Link to Instagram
  • Link to Pinterest
  • Link to Youtube
  • Contact Us
  • About Us
  • Press & Mentions
  • Careers
  • Meet the Founder
  • Privacy Policy
  • Editorial Ethics
  • Methodology
  • Corrections
  • Disclosure
  • Terms and Conditions
Scroll to top Scroll to top Scroll to top